Please check your internet connection and try again.
# Walethmade bromide
## Overview
**Note:** There is no FDA-approved medication or clinically recognized pharmaceutical agent under the name "Walethmade bromide." It appears this may be a typo or a misidentified substance. If you are referring to a different agent (e.g., Anisindione, various bromide salts, or a veterinary-specific compound), please verify the generic name.
## Primary Indications
None established. In the context of "bromide" salts, historical use included sedatives or anticonvulsants, though these are largely obsolete due to narrow therapeutic indices and accumulation risks.
## Adult Dosing
No established dosing. Bromides (if referring to older anticonvulsants) typically had prolonged half-lives (10–12 days), requiring extremely slow titration and serum level monitoring. Use is not recommended.
## Pediatric Dosing
Not established. Use is generally contraindicated in pediatric populations due to potential for bromism (neurological toxicity).
## Dose Adjustments
N/A. If referring to historic bromide salts: Dose reduction is mandatory in renal impairment, as bromide is excreted exclusively via the kidneys and competes with chloride for clearance.
## Contraindications
Hypersensitivity to bromide ions; severe renal impairment; patients with significant clinical depression or suicidal ideation (historical caution).
## Adverse Effects
Common: Bromism, characterized by skin eruptions (acneiform rash), fatigue, ataxia, tremors, impaired memory, irritability, confusion, and psychosis.
Severe: Coma, delirium, and respiratory depression.
## Key Drug Interactions
Pharmacodynamic interactions: Additive CNS depression with benzodiazepines, opioids, and alcohol.
Pharmacokinetic interactions: Dietary chloride intake significantly impacts bromide clearance; increased chloride intake accelerates bromide excretion.
## Monitoring
Not applicable for current clinical practice. If used historically: Serum bromide concentrations (therapeutic range traditionally 8–15 mmol/L; toxicity often >20 mmol/L).
## Clinical Pearls
1. **Verification Required:** Double-check the spelling of the drug name. If this is a proprietary or international name, provide the manufacturer or active chemical structure.
2. **Bromide Toxicity:** Diagnosis of bromism requires measuring serum bromide levels; standard laboratory electrolyte panels do not report this.
3. **Clinical Obsolescence:** If the intended drug was a brominated compound, safer modern alternatives (e.g., valproate, levetiracetam for seizures) have rendered bromides clinically obsolete.
***
*Educational Disclaimer: This information is for educational purposes only. There is no recognized drug named "Walethmade bromide." Clinicians must verify all drug names, indications, and dosages through official institutional formularies, the FDA/EMA database, or current clinical software (e.g., Lexicomp, Micromedex) before prescribing or administering any medication.*
